Add Company
Join Now

ImmunoGenesis Revenue and Competitors

License our Company Data API

Houston, TX USA

Location

$23.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ImmunoGenesis's estimated annual revenue is currently $1.6M per year.(i)
  • ImmunoGenesis's estimated revenue per employee is $77,500
  • ImmunoGenesis's total funding is $23.5M.

Employee Data

  • ImmunoGenesis has 20 Employees.(i)
  • ImmunoGenesis grew their employee count by 18% last year.

ImmunoGenesis's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Founder and SAB HeadReveal Email/Phone
3
SVP, Clinical DevelopmentReveal Email/Phone
4
Director, R&DReveal Email/Phone
5
N/AReveal Email/Phone
6
Consultant Preclinical LeadReveal Email/Phone
7
Clinical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is ImmunoGenesis?

ImmunoGenesis is a clinical-stage biotechnology company developing therapeutics to provide more consistent benefit to patients with immune-infiltrated tumors and for the first time catalyze effective immune responses in immunologically “cold” cancers such as prostate, colorectal and pancreatic cancer. These tumor types represent more than half of all cancers, and current immunotherapies have shown limited to no efficacy here. As a result, there is a high unmet need and substantial market opportunity for efficacious therapies.

keywords:N/A

$23.5M

Total Funding

20

Number of Employees

$1.6M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M20-23%N/A
#2
$2.5M20-9%$750M
#3
$2M20N/AN/A
#4
$3.6M200%N/A
#5
$2.3M20-20%N/A